Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
S1-Leitlinie: Kaposi-Sarkom.
Esser S, Schöfer H, Hoffmann C, Claßen J, Kreuter A, Leiter U, Oette M, Becker JC, Ziemer M, Mosthaf F, Sirokay J, Ugurel S, Potthoff A, Helbig D, Bierhoff E, Schulz TF, Brockmeyer NH, Grabbe S. Esser S, et al. Among authors: sirokay j. J Dtsch Dermatol Ges. 2022 Jun;20(6):892-905. doi: 10.1111/ddg.14788_g. J Dtsch Dermatol Ges. 2022. PMID: 35711056
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.
Leiter U, Loquai C, Reinhardt L, Rafei-Shamsabadi D, Gutzmer R, Kaehler K, Heinzerling L, Hassel JC, Glutsch V, Sirokay J, Schlecht N, Rübben A, Gambichler T, Schatton K, Pfoehler C, Franklin C, Terheyden P, Haferkamp S, Mohr P, Bischof L, Livingstone E, Zimmer L, Weichenthal M, Schadendorf D, Meiwes A, Keim U, Garbe C, Becker JC, Ugurel S. Leiter U, et al. Among authors: sirokay j. J Immunother Cancer. 2020 Oct;8(2):e000897. doi: 10.1136/jitc-2020-000897. J Immunother Cancer. 2020. PMID: 33093156 Free PMC article.
Therapieresistentes Erythem der Rima ani.
Poortinga S, Wilsmann-Theis D, Bieber T, Wenzel J, Maier J, Sirokay J, Landsberg J, Altengarten J, Balakirski G. Poortinga S, et al. Among authors: sirokay j. J Dtsch Dermatol Ges. 2020 Dec;18(12):1518-1521. doi: 10.1111/ddg.14168_g. J Dtsch Dermatol Ges. 2020. PMID: 33373158 German. No abstract available.
S1 Guidelines for the Kaposi Sarcoma.
Esser S, Schöfer H, Hoffmann C, Claßen J, Kreuter A, Leiter U, Oette M, Becker JC, Ziemer M, Mosthaf F, Sirokay J, Ugurel S, Potthoff A, Helbig D, Bierhoff E, Schulz TF, Brockmeyer NH, Grabbe S. Esser S, et al. Among authors: sirokay j. J Dtsch Dermatol Ges. 2022 Jun;20(6):892-904. doi: 10.1111/ddg.14788. Epub 2022 Jun 3. J Dtsch Dermatol Ges. 2022. PMID: 35657085
Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition.
Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, Hassel JC, Weishaupt C, Eigentler T, Schilling B, Schummer P, Sirokay J, Kiecker F, Owen CN, Fleischer MI, Cann C, Kähler KC, Mohr P, Bluhm L, Niebel D, Thoms KM, Goldinger SM, Reinhardt L, Meier F, Berking C, Reinhard R, Susok L, Ascierto PA, Drexler K, Pföhler C, Tietze J, Heinzerling L, Livingstone E, Ugurel S, Long GV, Stang A, Schadendorf D, Zimmer L. Knispel S, et al. Among authors: sirokay j. Eur J Cancer. 2021 May;148:61-75. doi: 10.1016/j.ejca.2021.01.034. Epub 2021 Mar 15. Eur J Cancer. 2021. PMID: 33735811
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional Trial.
Steeb T, Wessely A, von Bubnoff D, Dirschka T, Drexler K, Falkenberg C, Hassel JC, Hayani K, Hüning S, Kähler KC, Karrer S, Krammer C, Leiter U, Lill D, Marsela E, Meiwes A, Nashan D, Nasifoglu S, Schmitz L, Sirokay J, Thiem A, Utikal J, Zink A, Berking C, Heppt MV. Steeb T, et al. Among authors: sirokay j. J Clin Med. 2020 May 12;9(5):1438. doi: 10.3390/jcm9051438. J Clin Med. 2020. PMID: 32408601 Free PMC article.
Therapy-resistant erythema of the rima ani.
Poortinga S, Wilsmann-Theis D, Bieber T, Wenzel J, Maier J, Sirokay J, Landsberg J, Altengarten J, Balakirski G. Poortinga S, et al. Among authors: sirokay j. J Dtsch Dermatol Ges. 2020 Dec;18(12):1518-1521. doi: 10.1111/ddg.14168. Epub 2020 Jul 27. J Dtsch Dermatol Ges. 2020. PMID: 32717132 No abstract available.
Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A, Loick S, Bawden EG, Fietz S, Dietrich J, Diekmann E, Saavedra G, Fröhlich H, Niebel D, Sirokay J, Zarbl R, Gielen GH, Kristiansen G, Bootz F, Landsberg J, Dietrich D. Fröhlich A, et al. Among authors: sirokay j. EBioMedicine. 2020 Feb;52:102647. doi: 10.1016/j.ebiom.2020.102647. Epub 2020 Feb 3. EBioMedicine. 2020. PMID: 32028068 Free PMC article.
27 results